Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection
Keywords:
Klebsiella pneumoniae, Beta-lactamases, Urinary tract infections, Cephalosporins, IranAbstract
CONTEXT AND OBJECTIVES: Resistant bacteria are emerging worldwide as a threat to favorable outcomes from treating common infections in community and hospital settings. The present investigation was carried out to study the incidence of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae in patients with urinary tract infection in different seasons of the year, in order to determine the prevalence of the genes blaTEM, blaSHV and blaCTX-M, which are responsible for ESBL production among ESBL-producing K. pneumoniae, in three cities in Iran, and to investigate the antimicrobial susceptibility pattern of K. pneumoniae in different seasons. DESIGN AND SETTING: Retrospective study carried out among patients with urinary tract infections in five hospitals in Iran. METHOD: Two hundred and eighty-eight clinical isolates of K. pneumoniae were collected between March 2007 and April 2008 from five hospitals in three cities in Iran. ESBLs were identified by phenotypic and genotypic methods. ESBL-producing Klebsiella pneumoniae were evaluated against non-beta-lactam antibiotics. Genes coding for ESBLs (blaSHV, TEM and CTX-M) were screened. RESULTS: Among the 288 clinical isolates of K. pneumoniae, 37.7%, 46.7% and 15.6% were obtained from hospitals in Ilam, Tehran and Tabriz, respectively, of which 39.4%, 50.7% and 45.8% were ESBL-producing K. pneumoniae in Ilam, Milad and Emam Reza hospitals, respectively. CONCLUSION: According to the results from this study, resistance to third-generation cephalosporins is higher during the cold months than during the warm months.
Downloads
References
Chaudhary U, Aggarwal R. Extended spectrum -lactamases (ESBL) - an emerging threat to clinical therapeutics. Indian J Med Microbiol. 2004;22(2):75-80.
Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11(6):315-7.
Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933-51, table of contents.
Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657-86.
Winokur PL, Brueggemann A, DeSalvo DL, et al. Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob Agents Chemother. 2000;44(10):2777-83.
Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-
ceftazidime-hydrolyzing beta-lactamases in a single isolates. Antimicrob Agents Chemother. 1994;38(4):761-6.
Pangon B, Bizet C, Buré A, et al. In vivo selection of a cephamycin- resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. J Infect Dis. 1989;159(5):1005-6.
Sirot D. Extended-spectrum plasmid-mediated beta-lactamases. J Antimicrob Chemother. 1995;36 Suppl A:19-34.
Villa L, Pezzella C, Tosini F, et al. Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended- spectrum beta-lactamase gene and a class 1 integron. Antimicrob Agents Chemother. 2000;44(10):2911-4.
Paterson DL, Ko WC, Von Gottberg A, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol. 2001;39(6):2206-12.
Irajian G, Moghadas AJ. Frequency of extended-spectrum beta lactamase positive and multidrug resistance pattern in Gram- negative urinary isolates, Semnan, Iran. Jundishapur Journal of Microbiology. 2010;3(3):107-13. Available from: http://jjm.ajums.ac.ir/_jjm/documents/Issue%208GI.pdf. Accessed in 2011 (Jun 15).
Mac Faddin JF. Biochemical tests for identification of medical bacteria. 3rd ed. Philadelphia: Lippincott Williams & Wilkinson; 1999.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement, M100-S20. Wayne: Clinical and Laboratory Standards Institute; 2010. Available from: http://www.clsi.org/source/orders/free/m100-s20.pdf. Accessed in 2011 (Jun 15).
Paterson DL, Mulazimoglu L, Casellas JM, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000;30(3):473-8.
Shahcheraghi F, Moezi H, Feizabadi MM. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med Sci Monit. 2007;13(11):BR247-250.
Mansouri M, Ramazanzadeh R. Spread of extended-spectrum beta- lactamase producing Escherichia coli clinical isolates in Sanandaj Hospitals. Journal of Biological Sciences. 2009;9(4):362-66. Available from: http:// scialert.net/abstract/?doi=jbs.2009.362.366. Accessed in 2011 (Jun 15).
Bush K. The impact of beta-lactamases on the development of novel antimicrobial agents. Curr Opin Investig Drugs. 2002;3(9):1284-90.
Shannon K, Phillips I. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis. J Antimicrob Chemother. 1986;18 Suppl E:15-22.
Yu Y, Zhou W, Chen Y, Ding Y, Ma Y. Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province. Chin Med J (Engl). 2002;115(10):1479-82.
Alzahrani AJ, Akhtar N. Susceptibility patterns of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolated in a teaching hospital. Pakistan Journal of Medical Research. 2005;44(2):64-7. Available from: http://www. pakmedinet.com/8334. Accessed in 2011 (Jun 15).
Podschun R, Ullmann C. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589-603.
Livermore DM. beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995;8(4):557-84.
Arlet G, Philippon A. Construction by polymerase chain reaction and use of intragenic DNA probes for three main types of transferable beta-lactamases (TEM, SHV, CARB) FEMS Microbiol Lett. 1991;66(1):19-25.
Elo J, Sarna S, Tallgren LG. Seasonal variations in the occurrence of urinary tract infections among children in an urban area in Finland. Ann Clin Res. 1979;11(3):101-6.
Stansfeld JM. Clinical observations relating to incidence and aetiology of urinary-tract infections in children. Be Med J. 1966;1(5488):631-5.
Behrooozi A, Rahbar M, Vand Yousefi J. Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from urine in an Iranian 1000-bed tertiary care hospital. African Journal of Microbiology Research. 2010;4(9):881-4. Available from: http://www.academicjournals.org/ajmr/PDF/Pdf2010/4May/Behrooozi%20et%20al.pdf. Accessed in 2011 (Jun 15).
Jain A, Mondal R. Prevalence & antimicrobial resistance pattern of extended spectrum beta-lactamase producing Klebsiella spp isolated from cases of neonatal septicaemia. Indian J Med Res. 2007;125(1):89-94.
Bameri Z, Chitsaz M, Owlia P. Detection of CTX-M - Lactamases in Isolated Klebsiella pneumoniae. Iranian Journal of Pathology. 2010;5(3):137-42. Available from: http://www.ijp.iranpath.org/IJPArticles/5_3/6.pdf. Accessed in 2011 (Jun 15).
Al-Agamy MH, Shibl AM, Tawfik AF. Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med. 2009;29(4):253-7.
Tasli H, Bahar IH. Molecular characterization of TEM- and SHV- derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey. Jpn J Infect Dis. 2005;58(3):162-7.
